Refine by MP, party, committee, province, or result type.

Results 1-7 of 7
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  Thank you for those questions. There were three, if I understood, and I'll answer them in the order you delivered them. The first was whether you could have a little bit more detail on the processes we've been undertaking and what we're doing around that. There are many and the

May 8th, 2008Committee meeting

Philip Waddington

Health committee  There were a couple of comments around resources. I would like to reiterate that a number of the members felt that we should be better resourced. I just want to put that back on the table. What we've been doing with our resources internally is twofold. We've been trying to alloc

May 8th, 2008Committee meeting

Philip Waddington

Health committee  We receive information around the risk of the product from a number of situations. When an application is made to us, we have a list of the ingredients. There are also products for which, unfortunately, applications have not been made, so those would be found in the marketplace.

May 8th, 2008Committee meeting

Philip Waddington

Health committee  I think that one goes to me. There were three parts, as I understand it, to your question. The first was about where the data goes with respect to ADR--adverse drug reactions. The reports of serious and unexpected adverse drug reactions or adverse product reactions for natural

May 8th, 2008Committee meeting

Philip Waddington

Health committee  Wrap up?

May 8th, 2008Committee meeting

Philip Waddington

Health committee  I'll turn very briefly then to the performance within the natural health products directorate. When I was here approximately two years ago, we had approved around 1,000 products and we had 100 site licences that had been processed by the directorate. Now we're at about 7,000 pro

May 8th, 2008Committee meeting

Philip Waddington

Health committee  Thank you very much for the opportunity to come here to speak with you once again, Mr. Chair and members, about the natural health products regulations. I believe everybody has the notes in front of you, so I won't read them word for word. I'll speak to the various points, and h

May 8th, 2008Committee meeting

Philip Waddington